If these polyclonal cells are modified to express a tumor-specific TCR, major histocompatibility complex (MHC)-restricted antigen recognition allows for tumor escape via disruption of antigen processing or presentation [6,7]. This evidence concerns the gene HLA-C and neoplasm.